Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review

References

• Robinson A, Van Voorhees AS, Hsu S, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012; 67:279–288.
   PubMed Web of Science ®Google Scholar
• Liao PB, Rubinson R, Howard R, et al. Annular pustular psoriasis–most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol. 2002;19:19–25.
   PubMed Web of Science ®Google Scholar
• Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol. 2007;21:762–765.
   PubMed Web of Science ®Google Scholar
• Posso-De Los Rios CJ, Pope E, Lara-Corrales I. A systematic review of systemic medications for pustular psoriasis in pediatrics. Pediatr Dermatol. 2014;31:430–439.
   PubMed Web of Science ®Google Scholar
• Popadic S, Nikolic M. Pustular psoriasis in childhood and adolescence: a 20-year single-center experience. Pediatr Dermatol. 2014;31:575–579.
   PubMed Web of Science ®Google Scholar
• Bronckers IM, Paller AS, van Geel MJ, et al. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Pediatr Drugs. 2015;17:373–384.
   PubMed Web of Science ®Google Scholar
• Dunn LK, Gaar LR, Yentzer BA, et al. Acitretin in dermatology: a review. J Drugs Dermatol. 2011;10:772–782.
   PubMed Web of Science ®Google Scholar
• Sbidian E, Maza A, Montaudie H, et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J Eur Acad Dermatol Venereol. 2011;25(Suppl 2):28–33.
   PubMed Web of Science ®Google Scholar
• Gautam M, Tahiliani H, Nadkarni N, et al. Acitretin in pediatric dermatoses. Indian J Paediatr Dermatol. 2016;17:87–94.
   Google Scholar
• Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295(Suppl 1):S43–S54.
   PubMed Web of Science ®Google Scholar
• Macrae DJ. The Council for International Organizations and Medical Sciences (CIOMS) guidelines on ethics of clinical trials. Proc Am Thorac Soc. 2007;4:176–178.
   Google Scholar
• Fialova J, Vojackova N, Vanousova D, et al. Juvenile generalized pustular psoriasis treated with etanercept. Dermatol Ther. 2014;27:105–108.
   PubMed Web of Science ®Google Scholar
• Luu M, Cordoro KM. The evolving role of biologics in the treatment of pediatric psoriasis. Skin Therapy Lett. 2013;18:1–4.
   PubMedGoogle Scholar
• Jesus AA, Osman M, Silva CA, et al. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum. 2011;63:4007–4017.
   PubMed Web of Science ®Google Scholar
• Haug V, Benoit S, Wohlleben M, et al. Annular pustular psoriasis in a 14-month-old girl: a therapeutic challenge. J Dermatolog Treat. 2017;28:520–522.
   PubMed Web of Science ®Google Scholar
• Pereira TM, Vieira AP, Fernandes JC, et al. Anti-TNF-alpha therapy in childhood pustular psoriasis. Dermatology. 2006;213:350–352.
   PubMed Web of Science ®Google Scholar
• Mazzatenta C, Martini P, Luti L, et al. Diffuse sterile pustular eruption with changing clinical features in a 2-year old. Pediatr Dermatol. 2005;22:250–253.
   PubMed Web of Science ®Google Scholar
• Papoutsaki M, Costanzo A, Mazzotta A, et al. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol. 2006;154:181–183.
   PubMed Web of Science ®Google Scholar
• Choo W. Extemporaneous compounding of oral acitretin suspension for pediatric patient with generalized pustular psoriasis. Int J Pharm Compd. 2016;20:6–10.
   PubMedGoogle Scholar
• Chao PH, Cheng YW, Chung MY. Generalized pustular psoriasis in a 6-week-old infant. Pediatr Dermatol. 2009;26:352–354.
   PubMed Web of Science ®Google Scholar
• de Oliveira ST, Maragno L, Arnone M, et al. Generalized pustular psoriasis in childhood. Pediatr Dermatol. 2010;27:349–354.
   PubMed Web of Science ®Google Scholar
• Alvarez AC, Rodriguez-Nevado I, De Argila D, et al. Recalcitrant pustular psoriasis successfully treated with adalimumab. Pediatr Dermatol. 2011;28:195–197.
   PubMed Web of Science ®Google Scholar
• Li SP, Tang WY, Lam WY, et al. Renal failure and cholestatic jaundice as unusual complications of childhood pustular psoriasis. Br J Dermatol. 2000;143:1292–1296.
   PubMed Web of Science ®Google Scholar
• Kopp T, Karlhofer F, Szepfalusi Z, et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol. 2004;151:912–916.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim GM, Kim SY. Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2006;23:306–308.
   PubMed Web of Science ®Google Scholar
• Marqueling AL, Cordoro KM. Systemic treatments for severe pediatric psoriasis. A Practical Approach. Dermatol Clin. 2013;31:267–288.
   PubMed Web of Science ®Google Scholar
• Ergin S, Ersoy-Evans S, Sahin S, et al. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatolog Treat. 2008;19:341–343.
   PubMedGoogle Scholar
• Kiszewski AE, De Villa D, Scheibel I, et al. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy. Pediatr Dermatol. 2009; 26:105–106.
   PubMed Web of Science ®Google Scholar
• Salleras M, Sanchez-Regana M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr Dermatol. 1995;12:231–234.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cheng R, Lu Z, et al. Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes. J Dermatol Sci. 2017; 85:235–240.
   PubMed Web of Science ®Google Scholar
• Ergun T, Seckin Gencosmanoglu D, Alpsoy E, et al. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: a multicenter, cohort study. J Dermatol. 2017; 44:630–634.
   PubMed Web of Science ®Google Scholar
• Lee CS, Li K. A review of acitretin for the treatment of psoriasis. Expert Opin Drug Saf. 2009;8:769–779.
   PubMed Web of Science ®Google Scholar
• Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643–659.
   PubMed Web of Science ®Google Scholar
• Marcoux D, Prost Y. Pediatric psoriasis revisited. J Cutan Med Surg. 2002;6:22–28.
   PubMedGoogle Scholar
• de Jager ME, de Jong EM, van de Kerkhof PC, et al. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62:1013–1030.
   PubMed Web of Science ®Google Scholar
• Saikaly SK, Mattes M. Biologics and pediatric generalized pustular psoriasis: an emerging therapeutic trend. Cureus. 2016;8:e652.
   PubMed Web of Science ®Google Scholar
• Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16:669–673.
   PubMed Web of Science ®Google Scholar
• Ozawa A, Ohkido M, Haruki Y, et al. Treatments of generalized pustular psoriasis: a multicenter study in Japan. J Dermatol. 1999; 26:141–149.
   PubMedGoogle Scholar
• Sugiura K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci. 2014;74:187–192.
   PubMed Web of Science ®Google Scholar
• Lassus A, Lauharanta J, Juvakoski T, et al. Efficacy of etretinate (Tigason) in clearing and prevention of relapse of palmoplantar pustulosis. Dermatologica. 1983;166:215–219.
   PubMedGoogle Scholar
• Foged E, Holm P, Larsen PO, et al. A randomized trial of etretinate (Tigason) in palmoplantar pustulosis. Dermatologica. 1983;166:220–223.
   PubMedGoogle Scholar
• Lassus A, Lauharanta J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol. 1985;112:455–459.
   PubMed Web of Science ®Google Scholar
• Lassus A, Geiger JM. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol. 1988;119:755–759.
   PubMed Web of Science ®Google Scholar
• Marsland AM, Griffiths CE. Treatments for chronic palmoplantar pustular psoriasis. Skin Therapy Lett. 2001;6:3–5.
   PubMedGoogle Scholar
• Adisen E, Tekin O, Gulekon A, et al. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol. 2009;23:814–819.
   PubMed Web of Science ®Google Scholar
• Silpa-archa N, Wongpraparut C. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept. J Med Assoc Thai. 2011;94:1154–1157.
   PubMedGoogle Scholar
• Dana S, Karin M. Induction of human growth hormone promoter activity by the adenosine 3′,5′-monophosphate pathway involves a novel responsive element. Mol Endocrinol. 1989;3:815–821.
   PubMedGoogle Scholar
• Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol. 2005;153:445–446.
   PubMedGoogle Scholar
• Ortiz NE, Nijhawan RI, Weinberg JM. Acitretin. Dermatol Ther. 2013;26:390–399.
   PubMed Web of Science ®Google Scholar
• Gollnick H, Bauer R, Brindley C, et al. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. J Am Acad Dermatol. 1988;19:458–468.
   PubMed Web of Science ®Google Scholar
• Matteo M, Maddalena N, Balato A, et al. Psoriasis in Children: A Review. Curr Pediatr Rev. 2015;11:10–26.
   PubMedGoogle Scholar
• Zhang XB, Luo Q, Li CX, et al. Clinical investigation of acitretin in children with severe inherited keratinization disorders in China. J Dermatolog Treat. 2008; 19:221–228.
   PubMed Web of Science ®Google Scholar
• Glover MT, Peters AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. Br J Dermatol. 1987;116:609–614.
   PubMed Web of Science ®Google Scholar
• Paige DG, Judge MR, Shaw DG, et al. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy. Br J Dermatol. 1992;127:387–391.
   PubMed Web of Science ®Google Scholar